187 related articles for article (PubMed ID: 26838076)
1. Hypoglycemia: Adverse Cardiovascular Outcomes in Non-Critically Ill People with Type 2 Diabetes.
Akhavan P; Aghili R; Malek M; Ebrahim Valojerdi A; Khamseh ME
Arch Iran Med; 2016 Feb; 19(2):82-6. PubMed ID: 26838076
[TBL] [Abstract][Full Text] [Related]
2. Severe hypoglycemia and risks of vascular events and death.
Zoungas S; Patel A; Chalmers J; de Galan BE; Li Q; Billot L; Woodward M; Ninomiya T; Neal B; MacMahon S; Grobbee DE; Kengne AP; Marre M; Heller S;
N Engl J Med; 2010 Oct; 363(15):1410-8. PubMed ID: 20925543
[TBL] [Abstract][Full Text] [Related]
3. Safety of once-daily insulin detemir in patients with type 2 diabetes treated with oral hypoglycemic agents in routine clinical practice.
Ross S; Dzida G; Ji Q; Kaiser M; Ligthelm R; Meneghini L; Nazeri A; Orozco-Beltran D; Pan C; Svendsen AL;
J Diabetes; 2014 May; 6(3):243-50. PubMed ID: 24103141
[TBL] [Abstract][Full Text] [Related]
4. Effects on All-cause Mortality and Cardiovascular Outcomes in Patients With Type 2 Diabetes by Comparing Insulin With Oral Hypoglycemic Agent Therapy: A Meta-analysis of Randomized Controlled Trials.
Li J; Tong Y; Zhang Y; Tang L; Lv Q; Zhang F; Hu R; Tong N
Clin Ther; 2016 Feb; 38(2):372-386.e6. PubMed ID: 26774276
[TBL] [Abstract][Full Text] [Related]
5. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
[TBL] [Abstract][Full Text] [Related]
6. Effects of fasting blood glucose levels and blood pressure and treatment of diabetes and hypertension on the incidence of cardiovascular disease: a study of 740 patients with incident Type 2 diabetes with up to 30 years' follow-up.
Jansson SP; Svärdsudd K; Andersson DK
Diabet Med; 2014 Sep; 31(9):1055-63. PubMed ID: 24894815
[TBL] [Abstract][Full Text] [Related]
7. Severe hypoglycemia and mortality after cardiovascular events for type 1 diabetic patients in Sweden.
Lung TW; Petrie D; Herman WH; Palmer AJ; Svensson AM; Eliasson B; Clarke PM
Diabetes Care; 2014 Nov; 37(11):2974-81. PubMed ID: 25092684
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial.
Mellbin LG; Malmberg K; Waldenström A; Wedel H; Rydén L;
Heart; 2009 May; 95(9):721-7. PubMed ID: 19029171
[TBL] [Abstract][Full Text] [Related]
9. Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: results from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive 10).
Wilcox R; Kupfer S; Erdmann E;
Am Heart J; 2008 Apr; 155(4):712-7. PubMed ID: 18371481
[TBL] [Abstract][Full Text] [Related]
10. Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype.
Standl E; Stevens SR; Armstrong PW; Buse JB; Chan JCN; Green JB; Lachin JM; Scheen A; Travert F; Van de Werf F; Peterson ED; Holman RR;
Diabetes Care; 2018 Mar; 41(3):596-603. PubMed ID: 29311155
[TBL] [Abstract][Full Text] [Related]
11. Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer.
Holden SE; Jenkins-Jones S; Morgan CL; Schernthaner G; Currie CJ
Diabetes Obes Metab; 2015 Apr; 17(4):350-62. PubMed ID: 25399739
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
Tandon N; Ali MK; Narayan KM
Am J Cardiovasc Drugs; 2012 Feb; 12(1):7-22. PubMed ID: 22217193
[TBL] [Abstract][Full Text] [Related]
13. Confirming the Bidirectional Nature of the Association Between Severe Hypoglycemic and Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL.
Standl E; Stevens SR; Lokhnygina Y; Bethel MA; Buse JB; Gustavson SM; Maggioni AP; Mentz RJ; Hernandez AF; Holman RR;
Diabetes Care; 2020 Mar; 43(3):643-652. PubMed ID: 31882409
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting hypoglycemia awareness in insulin-treated type 2 diabetes: The Diabetes Outcomes in Veterans Study (DOVES).
Murata GH; Duckworth WC; Shah JH; Wendel CS; Hoffman RM;
Diabetes Res Clin Pract; 2004 Jul; 65(1):61-7. PubMed ID: 15163479
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome.
Esteghamati A; Abbasi M; Nakhjavani M; Yousefizadeh A; Basa AP; Afshar H
Cardiovasc Diabetol; 2006 Jul; 5():15. PubMed ID: 16842631
[TBL] [Abstract][Full Text] [Related]
16. Cost and co-morbidities associated with hypoglycemic inpatients in Belgium.
Chevalier P; Vandebrouck T; De Keyzer D; Mertens A; Lamotte M
J Med Econ; 2016; 19(1):44-52. PubMed ID: 26428944
[TBL] [Abstract][Full Text] [Related]
17. Vital signs, QT prolongation, and newly diagnosed cardiovascular disease during severe hypoglycemia in type 1 and type 2 diabetic patients.
Tsujimoto T; Yamamoto-Honda R; Kajio H; Kishimoto M; Noto H; Hachiya R; Kimura A; Kakei M; Noda M
Diabetes Care; 2014; 37(1):217-25. PubMed ID: 23939540
[TBL] [Abstract][Full Text] [Related]
18. Severe hypoglycemia and the risk of cardiovascular disease and mortality in type 2 diabetes: a nationwide population-based cohort study.
Yun JS; Park YM; Han K; Cha SA; Ahn YB; Ko SH
Cardiovasc Diabetol; 2019 Aug; 18(1):103. PubMed ID: 31412855
[TBL] [Abstract][Full Text] [Related]
19. A probabilistic model for predicting hypoglycemia in type 2 diabetes mellitus: The Diabetes Outcomes in Veterans Study (DOVES).
Murata GH; Hoffman RM; Shah JH; Wendel CS; Duckworth WC
Arch Intern Med; 2004 Jul; 164(13):1445-50. PubMed ID: 15249354
[TBL] [Abstract][Full Text] [Related]
20. High incidence of hypoglycemia in stable insulin-treated type 2 diabetes mellitus: continuous glucose monitoring vs. self-monitored blood glucose. Observational prospective study.
Pazos-Couselo M; García-López JM; González-Rodríguez M; Gude F; Mayán-Santos JM; Rodríguez-Segade S; Rodríguez-García J; Casanueva F
Can J Diabetes; 2015 Oct; 39(5):428-33. PubMed ID: 26254702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
